🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 14 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Kentucky

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

10
Recruiting now
17
Studies tracked
Kentucky
Selected state
Active Phase 3
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
UCB Biopharma SRL · started 2025-04-07
Arizona · California · District of Columbia · Florida · Kentucky · Michigan · North Carolina · Ohio
NCT06921850 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Amgen · started 2023-11-16
California · Delaware · Florida · Illinois · Kentucky · Massachusetts · New Mexico · New York
NCT05920356 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Platinum-resistant Ovarian Cancer
Ascendis Pharma Oncology Division A/S · started 2022-01-11
California · Illinois · Kentucky · Massachusetts · New Jersey · New York · North Carolina · Ohio
NCT05081609 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Lumen Bioscience, Inc. · started 2024-08-29
California · Connecticut · Florida · Illinois · Kentucky · Michigan · Minnesota · New York
NCT05330182 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Ovarian Cancer, Non-small Cell Lung Cancer
Tubulis GmbH · started 2024-06-12
Alabama · Connecticut · Georgia · Kentucky · Massachusetts · New Jersey · New York · Ohio
NCT06303505 on ClinicalTrials.gov ↗
Recruiting Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. · started 2024-03-19
Alabama · Arkansas · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT04781140 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
Psoriatic Arthritis
Bristol-Myers Squibb · started 2021-07-15
Alabama · California · Illinois · Kentucky · Louisiana · Maryland · Michigan · Minnesota
NCT04908189 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2024-04-03
Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06312137 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
AbbVie · started 2025-11-25
Connecticut · Florida · Indiana · Kentucky · Massachusetts · Missouri · Ohio · Texas
NCT07155174 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma
BeOne Medicines · started 2022-03-10
California · Florida · Georgia · Illinois · Indiana · Iowa · Kansas · Kentucky
NCT05100862 on ClinicalTrials.gov ↗
Active
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Tachycardia, Ventricular, Arrhythmia, Ventricular
Boston Scientific Corporation · started 2021-07-20
Arizona · Arkansas · Florida · Georgia · Kentucky · Minnesota · New Jersey · New York
NCT04798768 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Atopic Dermatitis
UCB Biopharma SRL · started 2025-12-29
California · Florida · Georgia · Illinois · Indiana · Kentucky · Michigan · Nebraska
NCT07277660 on ClinicalTrials.gov ↗
Active
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
Non-Small Cell Lung Cancer
Razor Genomics · started 2020-09-11
California · Florida · Kentucky · Missouri · New Jersey · North Carolina · Oklahoma · Pennsylvania
NCT01817192 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals · started 2025-05-30
Arizona · Arkansas · Colorado · Connecticut · Florida · Georgia · Kentucky · Louisiana
NCT06784752 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC · started 2025-04-15
Connecticut · Kentucky · Louisiana · Massachusetts · New York · Oklahoma · Texas · Utah
NCT06843447 on ClinicalTrials.gov ↗
Recruiting Phase 2
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche · started 2025-03-05
Alaska · California · Colorado · Florida · Idaho · Illinois · Iowa · Kentucky
NCT06806033 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
DLBCL, Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC · started 2022-01-14
Arizona · California · Florida · Illinois · Kentucky · Maryland · Massachusetts · Michigan
NCT05139017 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 102 Florida · 94 Illinois · 59 Georgia · 53 Arizona · 50 Colorado · 50 Texas · 40 New York · 37 Alabama · 33 Connecticut · 32 Massachusetts · 31 Michigan · 28 Ohio · 28 Indiana · 25 North Carolina · 23 Maryland · 21

Browse by condition

Breast Cancer · 5 Advanced Solid Tumor · 4 Obesity · 4 Chronic Lymphocytic Leukemia · 3 Ovarian Cancer · 3 Non-small Cell Lung Cancer · 3 Ulcerative Colitis · 3 Crohn's Disease · 3 Diffuse Large B-Cell Lymphoma · 3 Small Lymphocytic Lymphoma · 2 Urinary Bladder Neoplasms · 2 Marginal Zone Lymphoma · 2 Multiple Myeloma · 2 Pulmonary Embolism · 2 Bladder Cancer · 2 Small Cell Lung Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/kentucky (Accessed: 14 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.